Prevalence rate of carnitine and zinc deficiency and the efficacy of levocarnitine injection therapy in dialysis patients with renal anemia
Not Applicable
- Conditions
- End-stage kidney disease undergoing hemodialysis or peritoneal dialysis with renal anemia.
- Registration Number
- JPRN-UMIN000025327
- Lead Sponsor
- ihon University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
(1) patients who had previously taken levocarnitine, either orally or injected; (2) patients who were taking carnitine or zinc preparation as a supplement; (3) patients who have difficulty communicating owing to dementia or other factors; (4) patients with acute inflammation; (5) patients taking an immunosuppressive drug, steroid, or antibiotic; and (6) patients with a history of blood transfusion within the past six months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of carnitine deficincy, Physical function, lean body mass, BMI
- Secondary Outcome Measures
Name Time Method Erythropoietin responsiveness index, Dose of erythropiesis stimulating agents, Hemoglobin, and zinc level